Sun Pharma and Ranbaxy Laboratories might take longer than usual to secure all regulatory clearances for their proposed merger, sources said. The merger, announced on April 6, is being studied by......
The Supreme Court on Wednesday asked the Andhra Pradesh High Court, which had passed an interim order staying the $ 4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two......
Ranbaxy Laboratories, set to be merged with Sun Pharmaceutical Industries, might again have to pay a hefty penalty to the US authorities for alleged violations at its Toansa factory in Punjab. The......
The capital markets regulator, Securities and Exchange Board of India, is likely to begin a preliminary inquiry into the $4-billion merger deal between pharma giants Sun Pharmaceutical and Ranbaxy......
India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner,......